search
icon
Filter
Select Therapy Area
Filters
Clear All Filters

Medshorts

By month
Oncology
Oncology
2 Min Read
29 Feb

Respiratory therapy before lung cancer surgery reduces postoperative air leakage and pain

According to a recent study, it was found that lung cancer patients who underwent preoperative respiratory therapy, showed reduction in postoperative air leakage and pain. The result of the study was published in Physiotherapy Research International: The Journal for Researchers and Clinicians in Physical Therapy.

The randomized controlled trial involved seventy-one patients, with an average age of 62.58 years. They were divided into a differentiated, experimental group (EG) that underwent preoperative respiratory therapy and a control group. Descriptive variables under study included gender, carcinogenic pathology, type of surgical incision and lung resection, presence of adhesions, and use of glue and endostapler. Quantitative values analyzed were age, body mass index, and forced expiratory volume.

The results showed that there were statistically significant differences in the EG on the first 2 days with respect to postoperative air leakage during the performance of physiotherapy techniques, food, and exercises. A decrease in air leakage during gait was seen on days 2-4 in EG. Pain was found to be elevated in CG on days 1-4, after doing physiotherapy every day, except the second day.

Based on the results, it can be concluded that patients in the EG showed effective reduction in postoperative air leakage and pain levels due to preoperative respiratory therapy when compared to the CG.

Respiratory therapy before lung cancer surgery reduces postoperative air leakage and pain

According to a recent study, it was found that lung cancer patients who underwent preoperative respiratory therapy, showed reduction in postoperative air leakage and pain. The result of the study was published in Physiotherapy Research International: The Journal for Researchers and Clinicians in Physical Therapy.

The randomized controlled trial involved seventy-one patients, with an average age of 62.58 years. They were divided into a differentiated, experimental group (EG) that underwent preoperative respiratory therapy and a control group. Descriptive variables under study included gender, carcinogenic pathology, type of surgical incision and lung resection, presence of adhesions, and use of glue and endostapler. Quantitative values analyzed were age, body mass index, and forced expiratory volume.

The results showed that there were statistically significant differences in the EG on the first 2 days with respect to postoperative air leakage during the performance of physiotherapy techniques, food, and exercises. A decrease in air leakage during gait was seen on days 2-4 in EG. Pain was found to be elevated in CG on days 1-4, after doing physiotherapy every day, except the second day.

Based on the results, it can be concluded that patients in the EG showed effective reduction in postoperative air leakage and pain levels due to preoperative respiratory therapy when compared to the CG.

button
Oncology
2 Min Read
29 Feb

Respiratory therapy before lung cancer surgery reduces postoperative air leakage and pain

According to a recent study, it was found that lung cancer patients who underwent preoperative respiratory therapy, showed reduction in postoperative air leakage and pain. The result of the study was published in Physiotherapy Research International: The Journal for Researchers and Clinicians in Physical Therapy.

The randomized controlled trial involved seventy-one patients, with an average age of 62.58 years. They were divided into a differentiated, experimental group (EG) that underwent preoperative respiratory therapy and a control group. Descriptive variables under study included gender, carcinogenic pathology, type of surgical incision and lung resection, presence of adhesions, and use of glue and endostapler. Quantitative values analyzed were age, body mass index, and forced expiratory volume.

The results showed that there were statistically significant differences in the EG on the first 2 days with respect to postoperative air leakage during the performance of physiotherapy techniques, food, and exercises. A decrease in air leakage during gait was seen on days 2-4 in EG. Pain was found to be elevated in CG on days 1-4, after doing physiotherapy every day, except the second day.

Based on the results, it can be concluded that patients in the EG showed effective reduction in postoperative air leakage and pain levels due to preoperative respiratory therapy when compared to the CG.

button
Vitamin
Vitamin
2 Min Read
29 Feb

High-dose vitamin D supplementation well-tolerated and effective in managing overactive bladder dry in children

According to a recent study, high-dose vitamin D supplementation (VDS) plus standard urotherapy (SU) is safe and efficacious in managing overactive bladder dry in children. This study’s findings were published in The Journal of Urology.

This 3-arm, randomized clinical trial included 303 pediatric patients. Out of these, 100 children were randomized to receive 8 weeks of high-dose VDS, which consisted of vitamin D3 drops encapsulated as soft capsules, 2400 IU/d, plus SU (VDS + SU group). The other groups were administered 5-10 mg/d of solifenacin plus SU (SOL + SU group; n=102), or SU alone (SU group; n=101). The primary outcome of the study was reduction in voiding frequency. Secondary outcomes included nocturia, quality of life score, improvement in urgency, participant satisfaction, and pediatric lower urinary tract symptom score. Also, the treatment-related adverse events were recorded for each group.

It was observed that the VDS + SU group showed greater improvements in voids/d than the SOL + SU group and the SU group post intervention. The greatest improvement in quality of life and pediatric lower urinary tract symptom scores was also seen in the VDS + SU group. Both the SOL + SU and SU groups showed similar patient satisfaction. The VDS + SU group did not exhibit an increased risk of treatment-emergent adverse events as found in the other groups.

Based on the above results, it can be concluded that high-dose of VDS plus SU, when given to children for managing overactive bladder dry, may be effective and well-tolerated and hence, may be used as a novel therapeutic option.

High-dose vitamin D supplementation well-tolerated and effective in managing overactive bladder dry in children

According to a recent study, high-dose vitamin D supplementation (VDS) plus standard urotherapy (SU) is safe and efficacious in managing overactive bladder dry in children. This study’s findings were published in The Journal of Urology.

This 3-arm, randomized clinical trial included 303 pediatric patients. Out of these, 100 children were randomized to receive 8 weeks of high-dose VDS, which consisted of vitamin D3 drops encapsulated as soft capsules, 2400 IU/d, plus SU (VDS + SU group). The other groups were administered 5-10 mg/d of solifenacin plus SU (SOL + SU group; n=102), or SU alone (SU group; n=101). The primary outcome of the study was reduction in voiding frequency. Secondary outcomes included nocturia, quality of life score, improvement in urgency, participant satisfaction, and pediatric lower urinary tract symptom score. Also, the treatment-related adverse events were recorded for each group.

It was observed that the VDS + SU group showed greater improvements in voids/d than the SOL + SU group and the SU group post intervention. The greatest improvement in quality of life and pediatric lower urinary tract symptom scores was also seen in the VDS + SU group. Both the SOL + SU and SU groups showed similar patient satisfaction. The VDS + SU group did not exhibit an increased risk of treatment-emergent adverse events as found in the other groups.

Based on the above results, it can be concluded that high-dose of VDS plus SU, when given to children for managing overactive bladder dry, may be effective and well-tolerated and hence, may be used as a novel therapeutic option.

button
Vitamin
2 Min Read
29 Feb

High-dose vitamin D supplementation well-tolerated and effective in managing overactive bladder dry in children

According to a recent study, high-dose vitamin D supplementation (VDS) plus standard urotherapy (SU) is safe and efficacious in managing overactive bladder dry in children. This study’s findings were published in The Journal of Urology.

This 3-arm, randomized clinical trial included 303 pediatric patients. Out of these, 100 children were randomized to receive 8 weeks of high-dose VDS, which consisted of vitamin D3 drops encapsulated as soft capsules, 2400 IU/d, plus SU (VDS + SU group). The other groups were administered 5-10 mg/d of solifenacin plus SU (SOL + SU group; n=102), or SU alone (SU group; n=101). The primary outcome of the study was reduction in voiding frequency. Secondary outcomes included nocturia, quality of life score, improvement in urgency, participant satisfaction, and pediatric lower urinary tract symptom score. Also, the treatment-related adverse events were recorded for each group.

It was observed that the VDS + SU group showed greater improvements in voids/d than the SOL + SU group and the SU group post intervention. The greatest improvement in quality of life and pediatric lower urinary tract symptom scores was also seen in the VDS + SU group. Both the SOL + SU and SU groups showed similar patient satisfaction. The VDS + SU group did not exhibit an increased risk of treatment-emergent adverse events as found in the other groups.

Based on the above results, it can be concluded that high-dose of VDS plus SU, when given to children for managing overactive bladder dry, may be effective and well-tolerated and hence, may be used as a novel therapeutic option.

button
Paediatric
Paediatric
2 Min Read
28 Feb

Novel biobased polyester cast provides matching stability to conventional fiberglass cast and improves patient satisfaction

According to a recent study, novel biobased polyester cast provides clinical outcomes similar to the conventional fiberglass casts and improves overall patient satisfaction in an eco-friendlier and safer way. This study was published in the journal, BMC Musculoskeletal Disorders.

This was a single-center, prospective, randomized trial that included 100 children with cast-immobilized stable upper limb fractures. They were randomly divided into either biobased polyester or synthetic fiberglass groups. All the patients were followed up till the cast removal which was done at approximately 3-4 weeks after immobilizing. Subjective patient questionnaire and objective clinical findings for the study were collected and analyzed.

Both the groups did not show any loss of reduction, based on the radiographs taken on the day of cast removal. Occurrence of skin problems was 3.4 times higher in the synthetic fiberglass group than in the biobased polyester group. The biobased polyester cast was preferred in every sub-item in the subjective questionnaire.

Based on the above results, it can be concluded that the novel biobased polyester cast may provide an improved patient satisfaction and matching stability to conventional fiberglass casts in an eco-friendlier and safer way.

Novel biobased polyester cast provides matching stability to conventional fiberglass cast and improves patient satisfaction

According to a recent study, novel biobased polyester cast provides clinical outcomes similar to the conventional fiberglass casts and improves overall patient satisfaction in an eco-friendlier and safer way. This study was published in the journal, BMC Musculoskeletal Disorders.

This was a single-center, prospective, randomized trial that included 100 children with cast-immobilized stable upper limb fractures. They were randomly divided into either biobased polyester or synthetic fiberglass groups. All the patients were followed up till the cast removal which was done at approximately 3-4 weeks after immobilizing. Subjective patient questionnaire and objective clinical findings for the study were collected and analyzed.

Both the groups did not show any loss of reduction, based on the radiographs taken on the day of cast removal. Occurrence of skin problems was 3.4 times higher in the synthetic fiberglass group than in the biobased polyester group. The biobased polyester cast was preferred in every sub-item in the subjective questionnaire.

Based on the above results, it can be concluded that the novel biobased polyester cast may provide an improved patient satisfaction and matching stability to conventional fiberglass casts in an eco-friendlier and safer way.

button
Paediatric
2 Min Read
28 Feb

Novel biobased polyester cast provides matching stability to conventional fiberglass cast and improves patient satisfaction

According to a recent study, novel biobased polyester cast provides clinical outcomes similar to the conventional fiberglass casts and improves overall patient satisfaction in an eco-friendlier and safer way. This study was published in the journal, BMC Musculoskeletal Disorders.

This was a single-center, prospective, randomized trial that included 100 children with cast-immobilized stable upper limb fractures. They were randomly divided into either biobased polyester or synthetic fiberglass groups. All the patients were followed up till the cast removal which was done at approximately 3-4 weeks after immobilizing. Subjective patient questionnaire and objective clinical findings for the study were collected and analyzed.

Both the groups did not show any loss of reduction, based on the radiographs taken on the day of cast removal. Occurrence of skin problems was 3.4 times higher in the synthetic fiberglass group than in the biobased polyester group. The biobased polyester cast was preferred in every sub-item in the subjective questionnaire.

Based on the above results, it can be concluded that the novel biobased polyester cast may provide an improved patient satisfaction and matching stability to conventional fiberglass casts in an eco-friendlier and safer way.

button

Courses

Therapy area
CoughRespiratory
button
CoughRespiratory
13 Oct 23
button

Videos

Derma
16 Feb 24
button
Derma
16 Feb 24
button
button